Briefing

From Office of Health Economics
Contact information at EDIRC.
Bibliographic data for series maintained by Publications Manager ( this e-mail address is bad, please contact ).

Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

002497: 2023 OHE Annual Report to the Charity Commission

Mireia Jofre-Bonet

002460: Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Office of Health Economics

002357: How is Quality of Life Measured for Health Technology Assessments?

Christopher Sampson

002218: 2018 OHE Annual Report to the Charity Commission

Office of Health Economics

002176: Documento de debate sobre la fijación de precios en función de la indicación (IBP) ¿Deben variar los precios de los medicamentos según la indicación?

Amanda Cole;Adrian Towse;Bernarda Zamora

002165: Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?

Amanda Cole;Adrian Towse;Bernarda Zamora

002146: How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Martina Garau

002084: Multi-Indication Pricing (MIP): Practical Solutions and Steps to Move Forward

Margherita Neri;Adrian Towse;Martina Garau

002079: 2017 OHE Annual Report to the Charity Commission

The Office of Health Economics

002055: Private Provision of Publicly Funded Health Care: The Economics of Ownership

Martin Chalkley

001922: Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help?

Margherita Neri;Adrian Towse

001842: Incentives for New Drugs to Tackle Anti-Microbial Resistance

Adrian Towse

001741: “New Age” Decision Making in HTA: Is It Applicable in Asia?

Amanda Cole;Grace Hampson;Nancy Devlin;David Grainger;Eui-Kyung Lee;Wija Oortwijn

001740: How Can Health Technology Assessments in the Asia-Pacific Area Respond to Increased Clinical Uncertainty as a Consequence of Expedited US and EU Regulatory Processes?

Amanda Cole;Adrian Towse;Michelle Mujoomdar;Arnold Chan;Franz Pichler

001583: Incentives to follow Best Practice in Health Care

Sarah Karlsberg-Schaffer;Jon Sussex;Yan Feng

000492: Developments in Economic Evaluation in Health Care: A Review of HEED

Clive Pritchard

000484: Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?

Paul Fenn;Alastair Gray;Neil Rickman;Rodrigo Salinas;Adrian Towse

000444: Trends in Economic Evaluation

Clive Pritchard

000439: GP Commissioning Groups – The Nottingham Experience

Stephen Earwicker

000438: From Efficacy to Cost-Effectiveness

Adrian Towse

000428: The Pros and Cons of Modelling in Economic Evaluation

Office of Health Economics

000427: Regulating Prices Paid by the NHS for Medicines Supplied by the UK-Based Pharmaceutical Industry

Martin Cave;Adrian Towse

000424: Health Financing and Pharmaceutical Policy Reform in the Countries of Central and Eastern Europe

Frans van Andel

000410: Handling Uncertainty in the Results of Economic Evaluation

Andrew Briggs

000407: The Impact of Behavioural and Biomedical Advance on Health Trends over the Next 25 Years

Mike Hall

000404: Heath Information and the Consumer

Jane Griffin

000401: The Impact of Unemployment on Health

Jane Griffin

000395: Aids in Africa: Meeting the Challenge through Training Education and Prevention

Office of Health Economics

000385: Factors Influencing Clinical Decisions in General Practice

Office of Health Economics

000383: Economic Evaluation of Growth Hormone Therapy

George Teeling Smith;Richard West

000380: Variations between General Practitioners

Ray Robinson;Jane Griffin

000379: The Economic Impact of Medicines

George Teeling Smith

000376: Coronary Heart Disease: The Need for Action

Office of Health Economics

000374: Impact of New Medicines on Health Care Costs

George Teeling Smith

000368: Cost-Benefit Analysis of Medicines – a Guide for Industry

George Teeling Smith

000364: HIV and AIDS in the United Kingdom

Nick Wells

000363: Health Services in Europe: 1988

George Teeling Smith

000347: Politics of Prescribing

Office of Health Economics

000335: Keep on Taking the Tablets? A Review of the Problem of Patient Non-Compliance

George Teeling Smith

000330: Medicines and the Quality of Life

George Teeling Smith

000329: Ill in Europe

John Vaizey

000325: Trends in European Health Spending

Office of Health Economics

000323: Sickness Absence – A Review

Nick Wells

000319: Doctors, Nurses and Midwives in the NHS

George Teeling Smith

000318: Disability in Britain – The Process of Transition

David Taylor

000316: Accidents in childhood

Nick Wells

000315: Mild Hypertension

George Teeling Smith

000311: End Stage Renal Failure

William Laing

000310: Effects of Prescription Charges

Office of Health Economics

000302: Perinatal Mortality in Britain – A Question of Class

Office of Health Economics